Stephen P. Robertson is EVP, General Counsel of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 443,824 shares of AUPH, which is worth approximately $2.53 Million. The most recent transaction as insider was on Mar 06, 2024, when has been sold 57,745 shares (Common Stock) at a price of $5.6 per share, resulting in proceeds of $323,372. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 444K
0% 3M change
46.3% 12M change
Total Value Held $2.53 Million

Stephen P. Robertson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 06 2024
SELL
Open market or private sale
$323,372 $5.6 p/Share
57,745 Reduced 11.51%
443,824 Common Stock
Feb 20 2024
BUY
Grant, award, or other acquisition
-
194,230 Added 27.91%
501,569 Common Stock
Mar 02 2023
SELL
Open market or private sale
$173,453 $8.94 p/Share
19,402 Reduced 6.01%
303,364 Common Stock
Mar 02 2023
BUY
Grant, award, or other acquisition
-
204,810 Added 38.82%
322,766 Common Stock
Mar 02 2022
BUY
Grant, award, or other acquisition
-
8,500 Added 42.12%
11,682 Common Stock
Jan 28 2021
BUY
Open market or private purchase
$14,526 $16.14 p/Share
900 Added 24.86%
2,720 Common Stock
SPR

Stephen P. Robertson

EVP, General Counsel
1203 4464 Markham Street, A1

Track Institutional and Insider Activities on AUPH

Follow Aurinia Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUPH shares.

Notify only if

Insider Trading

Get notified when an Aurinia Pharmaceuticals Inc. insider buys or sells AUPH shares.

Notify only if

News

Receive news related to Aurinia Pharmaceuticals Inc.

Track Activities on AUPH